Immune Response News and Research

RSS

Gender matching key for corneal transplants? An interview with Professor Kaye

The cornea is a transparent tissue lining the front of the eye, that is invisible tissue to the naked eye. It is a delicate tissue and disease or injury may lead to a loss of transparency or a change in the shape of the cornea, resulting in severe visual impairment.

19 Sep 2016

Researchers discover how mineral ion leaked from dying tumour tissue stops work of immune cells

Researchers at the National Cancer Institute in the USA and the Babraham Institute, UK, have discovered how a mineral ion leaked from tumour tissue as it dies acts to stop the work of anti-tumour immune cells.

18 Sep 2016

Researchers explain novel approach for analyzing diverse immune responses

The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Pasteur / Inserm) and Dr Lluis Quintana-Murci (Human Evolutionary Genetics Unit, Institut Pasteur / CNRS) seek to establish the parameters that characterize the immune system of healthy individuals and its natural variability.

16 Sep 2016

Research may help explain mechanism by which Zika virus breaches placental barrier

New research reveals that in pregnant women, Zika virus infection damages certain cells that affect placental formation and function. Furthermore, herpes simplex virus-2 (HSV-2) infection augments placental sensitivity to Zika virus by enhancing the expression of receptors that allow Zika virus to enter cells.

15 Sep 2016

Research findings may pave way for innovative treatments of multiple sclerosis

Researchers at the Research Center for Immunotherapy and the Focus Program Translational Neurosciences of Johannes Gutenberg University Mainz have identified a new mechanism that is involved in the development of autoimmune diseases.

14 Sep 2016

Study shows possibility to achieve immunological antibody memory with mucosal vaccination

If a vaccine is to protect the intestines and other mucous membranes in the body, it also needs to be given through the mucosa, for example as a nasal spray or a liquid that is drunk.

14 Sep 2016

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.

14 Sep 2016

Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.

14 Sep 2016

Steroids for treating infertility in women may have harmful effects on pregnancy and child

Researchers at the University of Adelaide are urging doctors and patients to refrain from using a specific steroid treatment to treat infertility in women unless clinically indicated, because of its links to miscarriage, preterm birth and birth defects.

9 Sep 2016

Trial of high-dose flu vaccine aims to better protect heart failure patients

A network of researchers in the United States and Canada will try to spare thousands of patients the dangers of heart attacks and hospitalizations over the next five years in a trial of a high-dose flu vaccine.

8 Sep 2016

Stealth insulin-producing pig cells may offer solution for treating Type 1 diabetes in humans

University of Alabama at Birmingham researchers are exploring ways to wrap pig tissue with a protective coating to ultimately fight diabetes in humans. The nano-thin bilayers of protective material are meant to deter or prevent immune rejection.

8 Sep 2016

New blood test helps identify bacterial infection in infants with fever

A blood test used to measure patterns of ribonucleic acid (RNA) expression can help determine if fever in infants under 2 months old is caused by bacterial or viral infection, according to a preliminary study recently published in the Journal of the American Medical Association.

8 Sep 2016

Researchers discover second line of defense in macaques co-infected with Mtb and SIV

Tulane University researchers found some monkeys whose immune systems are depleted by the simian strain of HIV have a second line of defense against tuberculosis.

7 Sep 2016

Enzyme from oral bacteria could be potential therapy for celiac disease

Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease (CD), an autoimmune disorder that causes severe digestive and other health problems among sufferers when they consume gluten.

6 Sep 2016

New discovery offers way to develop vaccine against highly infectious bacteria

Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria--responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."

5 Sep 2016

Gut bacteria may play role in immune recovery of HIV patients

An international study coordinated by Spanish research institutes has found that gut bacteria also play their role in the immune recovery of HIV patients.

5 Sep 2016

New discovery could potentially lead to treatments for Crohn's disease

Scientists at the University of British Columbia have made a discovery that could potentially lead to treatments for a debilitating complication of Crohn's disease.

2 Sep 2016

Moderation and appropriate rest periods may be key to healthier CrossFit workouts

Are you a fitness enthusiast? If so, moderation and appropriate rest periods may be the key to healthier exercise, as consecutive CrossFit-style workouts could impair the immune system by affecting inflammatory proteins.

1 Sep 2016

Researchers discover protein that plays role in onset of type 1 diabetes

A new study reveals a counterintuitive cellular strategy that may protect insulin-producing cells from destruction during type 1 diabetes.

31 Aug 2016

Leading Chikungunya vaccine in clinical trial phase 2

With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.

29 Aug 2016

Immune Response News and Research

Gender matching key for corneal transplants? An interview with Professor Kaye

Researchers discover how mineral ion leaked from dying tumour tissue stops work of immune cells

Researchers explain novel approach for analyzing diverse immune responses

Research may help explain mechanism by which Zika virus breaches placental barrier

Research findings may pave way for innovative treatments of multiple sclerosis

Study shows possibility to achieve immunological antibody memory with mucosal vaccination

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

Steroids for treating infertility in women may have harmful effects on pregnancy and child

Trial of high-dose flu vaccine aims to better protect heart failure patients

Stealth insulin-producing pig cells may offer solution for treating Type 1 diabetes in humans

New blood test helps identify bacterial infection in infants with fever

Researchers discover second line of defense in macaques co-infected with Mtb and SIV

Enzyme from oral bacteria could be potential therapy for celiac disease

New discovery offers way to develop vaccine against highly infectious bacteria

Gut bacteria may play role in immune recovery of HIV patients

New discovery could potentially lead to treatments for Crohn's disease

Moderation and appropriate rest periods may be key to healthier CrossFit workouts

Researchers discover protein that plays role in onset of type 1 diabetes

Leading Chikungunya vaccine in clinical trial phase 2

Understanding the DNA Damage Response in Innate Immunity eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News